These studies suggest that depending on CCR5 ligand concentration and other signaling pathways (e.g., LCN2), CCR5 and its ligands may have dose-dependent roles in neuronal damage and cognitive deficits caused by HIV infection. This evidence concerns the gene CCR5 and Cognitive impairment.